Two new ERC funding for the CIML attributed to Michael Sieweke and for a second time to Eric Vivier. Two ERC "Advanced Grants" for their respective projects: Macrophage Aging and Rejuvenation (MacAge) and TILC (Targeting Innate Lymphoid Cells).
ERC Advanced Grants are designed to allow outstanding research leaders of any nationality and any age to pursue ground-breaking, high-risk projects in Europe. The scheme targets researchers who have already established themselves as top independent research leaders.
